공시 • May 08
Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026 Creotech Instruments S.A., Annual General Meeting, Jun 03, 2026, at 14:00 Central European Standard Time. 공시 • Apr 04
Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. Creotech Instruments S.A. (WSE:CRI) agreed to Spin-Off Quantum segments on April 17, 2025. As part of the spinoff, Creotech Instruments shareholders will be allocated shares in the new quantum company in proportion to their holdings. The allocation of shares will take place through a public offering of shares. The quantum company is expected to go public on the WSE, at the same time, a new company will be created to focus on the development and commercialization of quantum systems so far developed at Creotech and assuming the prospectus procedure before Poland's financial market regulator KNF and the receival of all corporate approvals proceeds without delay and the spinoff proposal receives the approval of the shareholders. The estimated date for concluding the spinoff is late 2025/early 2026.
Creotech Instruments S.A. (WSE:CRI) completed the Spin-Off of Creotech Quantum S.A. on April 2, 2026. Final record date for entitlement to the distribution is April 2, 2026. Creotech Quantum debut on WSE scheduled for April 17, 2026. 공시 • Aug 25
Creotech Instruments S.A. to Report First Half, 2025 Results on Sep 26, 2025 Creotech Instruments S.A. announced that they will report first half, 2025 results on Sep 26, 2025 공시 • May 19
Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025 Creotech Instruments S.A., Annual General Meeting, Jun 16, 2025. Reported Earnings • Oct 01
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: zł8.33m (down 11% from 2Q 2023). Net loss: zł4.22m (loss widened 17% from 2Q 2023). New Risk • Sep 30
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: €89.1m (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 92% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (20% increase in shares outstanding). Market cap is less than US$100m (€89.1m market cap, or US$99.2m). New Risk • Aug 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). 공시 • May 21
Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024 Creotech Instruments S.A., Annual General Meeting, Jun 24, 2024. New Risk • Mar 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). New Risk • Feb 13
New major risk - Revenue and earnings growth Revenue has declined by 8.5% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Revenue has declined by 8.5% over the past year. Minor Risk Shareholders have been diluted in the past year (20% increase in shares outstanding). New Risk • Dec 11
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 20% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (20% increase in shares outstanding). New Risk • Oct 11
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (€89.3m market cap, or US$94.8m). 공시 • Jun 04
Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023 Creotech Instruments S.A., Annual General Meeting, Jun 30, 2023, at 10:00 Central European Standard Time. Reported Earnings • Nov 27
Third quarter 2022 earnings released Third quarter 2022 results: Revenue: zł4.91m (down 26% from 3Q 2021). Net loss: zł2.24m (down 451% from profit in 3Q 2021). Reported Earnings • Oct 04
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: zł2.59m (down 61% from 2Q 2021). Net loss: zł2.93m (down zł3.57m from profit in 2Q 2021). 공시 • Jul 26
Creotech Instruments S.A. to Report Q2, 2023 Results on Sep 28, 2022 Creotech Instruments S.A. announced that they will report Q2, 2023 results on Sep 28, 2022 공시 • Jun 07
Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022 Creotech Instruments S.A., Annual General Meeting, Jun 30, 2022, at 14:00 Central European Standard Time.